Pacer Advisors’s Insmed INSM Stock Holding History

Pacer Advisors’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.19M	Sell	7,279 -8,304	-53%	-$1.28M	﹤0.01%	1138
2025 Q4	$2.71M	Buy	+15,583	New	+$2.84M	0.01%	935
2024 Q3	–	Sell	-638	Closed	-$42.7K	–	2621
2024 Q2	$42.7K	Sell	638 -898	-58%	-$34.8K	﹤0.01%	3244
2024 Q1	$41.7K	Buy	+1,536	New	+$43K	﹤0.01%	3242
2021 Q2	–	Sell	-1,990	Closed	-$68K	–	1475
2021 Q1	$68K	Sell	1,990 -1,328	-40%	-$50.8K	﹤0.01%	1389
2020 Q4	$110K	Sell	3,318 -548	-14%	-$20K	﹤0.01%	1353
2020 Q3	$124K	Buy	+3,866	New	+$111K	﹤0.01%	1230
2018 Q4	–	Sell	-7,658	Closed	-$155K	–	788
2018 Q3	$155K	Buy	+7,658	New	+$173K	0.01%	1051
2018 Q1	–	Sell	-625	Closed	-$19K	–	1084
2017 Q4	$19K	Buy	+625	New	+$18.5K	﹤0.01%	1098

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Pacer Advisors's INSM Position: Q1 2026 in Review

Pacer Advisors reduced its Insmed (INSM) stake by 53% in Q1 2026, selling an estimated $1.28M and leaving 7,279 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1138.

Pacer Advisors first reported a position in INSM in Q4 2017 and has held it in 9 quarters since. The position peaked at $2.71M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Pacer Advisors held 7,279 shares of Insmed worth $1.19M as of Q1 2026.
Pacer Advisors sold 8,304 Insmed shares in Q1 2026, an estimated $1.28M.
Insmed made up ﹤0.01% of Pacer Advisors's portfolio in Q1 2026, its #1138 holding.
Pacer Advisors first reported a position in Insmed in Q4 2017 and has held it in 9 quarters since.
Pacer Advisors's Insmed position peaked at $2.71M in Q4 2025.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.